China National Accord Medicines Corporation announcement, in the first three quarters of 2024, achieved revenue of 564.663 billion yuan, a year-on-year decrease of 0.21%; net income attributable to shareholders of the listed company was 1.066 billion yuan, a year-on-year decrease of 10.43%.
国药一致：前三季度净利润下降10.43%
China National Accord Medicines Corporation: Net income decreased by 10.43% in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated